Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy
Recruiting
Observational Study
Pancreatectomy
Enhanced Recovery After Surgery
Pancreatic Cancer Resectable
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 170 (estimated)
- Sponsor
- University of Thessaly · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study assesses whether patients with pancreatic cancer who undergo surgery experience improved outcomes following the implementation of a multidisciplinary care pathway, specifically an enhanced recovery after surgery (ERAS) program.
This pathway includes various interventions in the preoperative, intraoperative, and postoperative care of these patients, all aimed at enhancing their health s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients
* diagnosis of pancreatic cancer
* elective open pancreatic surgery
Exclusion Criteria:
* age \<18 years
* emergency pancreatic surgery
* other surgical procedures
* missing data
* lost to follow-up
Contacts